Business Context and Reporting Period
Sunshine Biopharma Inc. filed a Form 8-K on January 22, 2010, reporting a change in its fiscal year. The company is incorporated in Colorado with principal executive offices in Montreal, Quebec, Canada.
Financial Metrics
This filing does not provide revenue, profit, cash flow, margins, debt, or liquidity figures. The document focuses exclusively on a corporate governance change.
Material Changes
- Fiscal Year Change: Effective December 31, 2009, the Board of Directors adopted a resolution to change the fiscal year-end from July 31 to December 31.
- Rationale: The change was made to align the parent company's fiscal year with that of its wholly owned operating subsidiary.
- Authority: The change was authorized under Article VIII, Section 2 of the company's Bylaws.
Guidance, Outlook, and Risks
The company intends to file a transitional report on Form 10-K for the fiscal year ended December 31, 2009. No specific financial guidance, risk factors, or unusual items were disclosed in this report.
Key Facts for Investors
- Verify the upcoming transitional Form 10-K filing for the period ended December 31, 2009.
- Confirm the alignment of financial reporting periods with the wholly owned operating subsidiary.
- Note that no financial performance data is available in this specific 8-K filing.